An ultrafast ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry method for cannabidiol monitoring in pediatric refractory epilepsy
<p><strong>Background:</strong> Cannabidiol (CBD) is a nonpsychoactive natural product that has been increasingly used as a promising new drug for the management of neurological conditions such as refractory epilepsy. Development of rapid and sensitive methods to quantitate CBD is...
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Lippincott, Williams & Wilkins
2020
|